Columbia Pediatric Heart Valve Symposium: From Bench to Bedside is organized by Columbia University Medical Center (CUMC) and will be held during May 30 - 31, 2018 at Columbia University Morningside Campus- Vivian & Seymour Milstein Family Heart Center- Myrna Daniels Auditorium, New York, United States of America.
The target audience for this medical event is congenital and pediatric cardiac surgeons, pediatric cardiologists, pediatric interventional cardiologists, general pediatricians, intensivists, scientists and engineers interested in pediatric heart valve research and device development, RNs, NPs, PAs, and other medical professionals involved with the evaluation, diagnosis and/or management of patients with congenital heart disease. This CME Conference has been approved for a maximum of 10.25 AMA PRA Category 1 Credits.
Course Overview :
This is the First Annual Cardiovascular Therapy Course focusing on medical and surgical management of congenital heart valve disease, hosted by NewYork-Presbyterian/Columbia University Medical Center. This program represents a unique multidisciplinary collaboration between congenital and pediatric cardiac surgeons, pediatric cardiologists, pediatric interventional cardiologists and heart valve scientists, allowing for a truly comprehensive approach to the management of children and adults with congenital heart valve malformations.
This one and a half-day course will further educate on the surgical and interventional management of patients with congenital heart valve malformations. Lectures will be given by internationally recognized experts who will review standard and emerging treatments for patients with congenital heart valve malformations, address the newest and most innovative therapies and review clinical, basic science and translational research programs, exploring edge-cutting and disruptive concepts to develop new valve devices. Such collaboration will ultimately improve care in children and adults with congenital heart valve malformations, thanks to a constant dialogue and works from bench to bed and back from bed to bench. Didactic sessions, case presentations and interactive discussions will engender learning and improvement in the management of patients with the full spectrum of congenital heart valve malformations.
Learning Objectives :
• Discuss advances and emerging innovative surgical procedures and techniques for repair and replacement of congenital heart valves
• Describe advances and emerging innovative transcatheter therapies for valve replacement in children and adults with congenital valve malformations
• Identify current options for non-invasive imaging of congenital heart valve malformations
• Explain the outcomes of the most recent trials of surgical and transcatheter valve procedures
• Define the most recent concepts and advances in heart valve tissue engineering, heart valve device development and heart valve biology and mechanobiology.